GALLBLADDER NEOPLASMS
Clinical trials for GALLBLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new GALLBLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for GALLBLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: GALLBLADDER NEOPLASMS
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Breast cancer drugs may fight rare tumors with HER2 changes
Disease control Recruiting nowThis study tests two drugs, trastuzumab and pertuzumab, already approved for breast cancer, in people with other rare cancers that have a specific genetic change called HER2 amplification or mutation. About 30 adults and children with various tumor types will receive the drug com…
Matched conditions: GALLBLADDER NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 13, 2026 16:02 UTC